PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Most nanoparticle-based cancer therapeutic strategies seek to develop an effective individual cancer cell or metastatic
tumor treatment. Critical to the success of these therapies is to direct as much of the agent as possible to the targeted
tissue while avoiding unacceptable normal tissue complications. In this light, three different cisplatinum/magnetic
nanoparticle (mNP) administration regimens were investigated. The most important finding suggests that clinically
relevant doses of cisplatinum result in a significant increase in the tumor uptake of systemically delivered mNP. This
enhancement of mNP tumor uptake creates the potential for an even greater therapeutic ratio through the addition of
mNP based, intracellular hyperthermia.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Alicia A. Petryk, Andrew J. Giustini, Rachel E. Gottesman, P. Jack Hoopes, "Improved delivery of magnetic nanoparticles with chemotherapy cancer treatment," Proc. SPIE 8584, Energy-based Treatment of Tissue and Assessment VII, 85840H (26 February 2013); https://doi.org/10.1117/12.2007308